4th Sep 2015 15:14
LONDON (Alliance News) - PureTech Health PLC on Friday said has received a notice of allowance from the US Patent and Trademark Office for a patent related to its principal technology platform to treat hair loss.
The patent will be issued to its subsidiary Follica and will cover varying methods of disruption of the epidermis, followed by modulation through application of a number of different compounds, it said.
"This patent allowance represents another significant milestone towards commercialization for Follica as we advance development of our novel platform and product candidates." said David Tharp, Follica's vice president of corporate development.
"We are pleased to note the forthcoming issuance of this patent, providing additional intellectual property protection for a key technology exclusively licensed worldwide by Follica," added PureTech Chief Executive Daphne Zohar.
PureTech shares were up 1.4% to 147.00 pence per share on Friday afternoon.
By Joshua Warner; [email protected]; @JoshAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
PureTech